Global Plasma-derived Medical Product Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
According to our (Global Info Research) latest study, the global Plasma-derived Medical Product market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Plasma-derived Medical Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Plasma-derived Medical Product market size and forecasts, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma-derived Medical Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma-derived Medical Product market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma and Kedrion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Plasma-derived Medical Product market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Plasma-derived Medical Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasma-derived Medical Product, with revenue, gross margin and global market share of Plasma-derived Medical Product from 2018 to 2023.
Chapter 3, the Plasma-derived Medical Product competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Plasma-derived Medical Product market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma-derived Medical Product.
Chapter 13, to describe Plasma-derived Medical Product research findings and conclusion.
According to our (Global Info Research) latest study, the global Plasma-derived Medical Product market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Plasma-derived Medical Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Plasma-derived Medical Product market size and forecasts, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Plasma-derived Medical Product market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma-derived Medical Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma-derived Medical Product market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma and Kedrion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Plasma-derived Medical Product market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Others
- Hospital
- Retail Pharmacy
- Others
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Plasma-derived Medical Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasma-derived Medical Product, with revenue, gross margin and global market share of Plasma-derived Medical Product from 2018 to 2023.
Chapter 3, the Plasma-derived Medical Product competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Plasma-derived Medical Product market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma-derived Medical Product.
Chapter 13, to describe Plasma-derived Medical Product research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Plasma-derived Medical Product
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasma-derived Medical Product by Type
1.3.1 Overview: Global Plasma-derived Medical Product Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Plasma-derived Medical Product Consumption Value Market Share by Type in 2022
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Others
1.4 Global Plasma-derived Medical Product Market by Application
1.4.1 Overview: Global Plasma-derived Medical Product Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Plasma-derived Medical Product Market Size & Forecast
1.6 Global Plasma-derived Medical Product Market Size and Forecast by Region
1.6.1 Global Plasma-derived Medical Product Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Plasma-derived Medical Product Market Size by Region, (2018-2029)
1.6.3 North America Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.4 Europe Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.6 South America Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Plasma-derived Medical Product Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Medical Product Product and Solutions
2.1.4 Takeda Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma-derived Medical Product Product and Solutions
2.2.4 CSL Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma-derived Medical Product Product and Solutions
2.3.4 Grifols Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma-derived Medical Product Product and Solutions
2.4.4 Octapharma Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma-derived Medical Product Product and Solutions
2.5.4 Kedrion Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma-derived Medical Product Product and Solutions
2.6.4 LFB Group Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma-derived Medical Product Product and Solutions
2.7.4 Biotest Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma-derived Medical Product Product and Solutions
2.8.4 BPL Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Medical Product Product and Solutions
2.9.4 RAAS Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma-derived Medical Product Product and Solutions
2.10.4 CBPO Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma-derived Medical Product Product and Solutions
2.11.4 Hualan Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Plasma-derived Medical Product Product and Solutions
2.12.4 Tiantan Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Plasma-derived Medical Product Product and Solutions
2.13.4 Shuanglin Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Plasma-derived Medical Product Product and Solutions
2.14.4 Boya Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Plasma-derived Medical Product Product and Solutions
2.15.4 Yuanda Shuyang Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Plasma-derived Medical Product Product and Solutions
2.16.4 Weiguang Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Plasma-derived Medical Product Product and Solutions
2.17.4 Nanyue Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Plasma-derived Medical Product Product and Solutions
2.18.4 KM Biologics Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasma-derived Medical Product Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Plasma-derived Medical Product by Company Revenue
3.2.2 Top 3 Plasma-derived Medical Product Players Market Share in 2022
3.2.3 Top 6 Plasma-derived Medical Product Players Market Share in 2022
3.3 Plasma-derived Medical Product Market: Overall Company Footprint Analysis
3.3.1 Plasma-derived Medical Product Market: Region Footprint
3.3.2 Plasma-derived Medical Product Market: Company Product Type Footprint
3.3.3 Plasma-derived Medical Product Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasma-derived Medical Product Consumption Value and Market Share by Type (2018-2023)
4.2 Global Plasma-derived Medical Product Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2023)
5.2 Global Plasma-derived Medical Product Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasma-derived Medical Product Consumption Value by Type (2018-2029)
6.2 North America Plasma-derived Medical Product Consumption Value by Application (2018-2029)
6.3 North America Plasma-derived Medical Product Market Size by Country
6.3.1 North America Plasma-derived Medical Product Consumption Value by Country (2018-2029)
6.3.2 United States Plasma-derived Medical Product Market Size and Forecast (2018-2029)
6.3.3 Canada Plasma-derived Medical Product Market Size and Forecast (2018-2029)
6.3.4 Mexico Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Plasma-derived Medical Product Consumption Value by Type (2018-2029)
7.2 Europe Plasma-derived Medical Product Consumption Value by Application (2018-2029)
7.3 Europe Plasma-derived Medical Product Market Size by Country
7.3.1 Europe Plasma-derived Medical Product Consumption Value by Country (2018-2029)
7.3.2 Germany Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.3 France Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.5 Russia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.6 Italy Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Plasma-derived Medical Product Market Size by Region
8.3.1 Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2018-2029)
8.3.2 China Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.3 Japan Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.4 South Korea Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.5 India Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.7 Australia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Plasma-derived Medical Product Consumption Value by Type (2018-2029)
9.2 South America Plasma-derived Medical Product Consumption Value by Application (2018-2029)
9.3 South America Plasma-derived Medical Product Market Size by Country
9.3.1 South America Plasma-derived Medical Product Consumption Value by Country (2018-2029)
9.3.2 Brazil Plasma-derived Medical Product Market Size and Forecast (2018-2029)
9.3.3 Argentina Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Plasma-derived Medical Product Market Size by Country
10.3.1 Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2018-2029)
10.3.2 Turkey Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10.3.4 UAE Plasma-derived Medical Product Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Plasma-derived Medical Product Market Drivers
11.2 Plasma-derived Medical Product Market Restraints
11.3 Plasma-derived Medical Product Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasma-derived Medical Product Industry Chain
12.2 Plasma-derived Medical Product Upstream Analysis
12.3 Plasma-derived Medical Product Midstream Analysis
12.4 Plasma-derived Medical Product Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Plasma-derived Medical Product
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasma-derived Medical Product by Type
1.3.1 Overview: Global Plasma-derived Medical Product Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Plasma-derived Medical Product Consumption Value Market Share by Type in 2022
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Others
1.4 Global Plasma-derived Medical Product Market by Application
1.4.1 Overview: Global Plasma-derived Medical Product Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Plasma-derived Medical Product Market Size & Forecast
1.6 Global Plasma-derived Medical Product Market Size and Forecast by Region
1.6.1 Global Plasma-derived Medical Product Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Plasma-derived Medical Product Market Size by Region, (2018-2029)
1.6.3 North America Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.4 Europe Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.6 South America Plasma-derived Medical Product Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Plasma-derived Medical Product Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Medical Product Product and Solutions
2.1.4 Takeda Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma-derived Medical Product Product and Solutions
2.2.4 CSL Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma-derived Medical Product Product and Solutions
2.3.4 Grifols Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma-derived Medical Product Product and Solutions
2.4.4 Octapharma Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma-derived Medical Product Product and Solutions
2.5.4 Kedrion Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma-derived Medical Product Product and Solutions
2.6.4 LFB Group Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma-derived Medical Product Product and Solutions
2.7.4 Biotest Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma-derived Medical Product Product and Solutions
2.8.4 BPL Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Medical Product Product and Solutions
2.9.4 RAAS Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma-derived Medical Product Product and Solutions
2.10.4 CBPO Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma-derived Medical Product Product and Solutions
2.11.4 Hualan Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Plasma-derived Medical Product Product and Solutions
2.12.4 Tiantan Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Plasma-derived Medical Product Product and Solutions
2.13.4 Shuanglin Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Plasma-derived Medical Product Product and Solutions
2.14.4 Boya Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Plasma-derived Medical Product Product and Solutions
2.15.4 Yuanda Shuyang Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Plasma-derived Medical Product Product and Solutions
2.16.4 Weiguang Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Plasma-derived Medical Product Product and Solutions
2.17.4 Nanyue Bio Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Plasma-derived Medical Product Product and Solutions
2.18.4 KM Biologics Plasma-derived Medical Product Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasma-derived Medical Product Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Plasma-derived Medical Product by Company Revenue
3.2.2 Top 3 Plasma-derived Medical Product Players Market Share in 2022
3.2.3 Top 6 Plasma-derived Medical Product Players Market Share in 2022
3.3 Plasma-derived Medical Product Market: Overall Company Footprint Analysis
3.3.1 Plasma-derived Medical Product Market: Region Footprint
3.3.2 Plasma-derived Medical Product Market: Company Product Type Footprint
3.3.3 Plasma-derived Medical Product Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasma-derived Medical Product Consumption Value and Market Share by Type (2018-2023)
4.2 Global Plasma-derived Medical Product Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2023)
5.2 Global Plasma-derived Medical Product Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasma-derived Medical Product Consumption Value by Type (2018-2029)
6.2 North America Plasma-derived Medical Product Consumption Value by Application (2018-2029)
6.3 North America Plasma-derived Medical Product Market Size by Country
6.3.1 North America Plasma-derived Medical Product Consumption Value by Country (2018-2029)
6.3.2 United States Plasma-derived Medical Product Market Size and Forecast (2018-2029)
6.3.3 Canada Plasma-derived Medical Product Market Size and Forecast (2018-2029)
6.3.4 Mexico Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Plasma-derived Medical Product Consumption Value by Type (2018-2029)
7.2 Europe Plasma-derived Medical Product Consumption Value by Application (2018-2029)
7.3 Europe Plasma-derived Medical Product Market Size by Country
7.3.1 Europe Plasma-derived Medical Product Consumption Value by Country (2018-2029)
7.3.2 Germany Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.3 France Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.5 Russia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
7.3.6 Italy Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Plasma-derived Medical Product Market Size by Region
8.3.1 Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2018-2029)
8.3.2 China Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.3 Japan Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.4 South Korea Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.5 India Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
8.3.7 Australia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Plasma-derived Medical Product Consumption Value by Type (2018-2029)
9.2 South America Plasma-derived Medical Product Consumption Value by Application (2018-2029)
9.3 South America Plasma-derived Medical Product Market Size by Country
9.3.1 South America Plasma-derived Medical Product Consumption Value by Country (2018-2029)
9.3.2 Brazil Plasma-derived Medical Product Market Size and Forecast (2018-2029)
9.3.3 Argentina Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Plasma-derived Medical Product Market Size by Country
10.3.1 Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2018-2029)
10.3.2 Turkey Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Plasma-derived Medical Product Market Size and Forecast (2018-2029)
10.3.4 UAE Plasma-derived Medical Product Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Plasma-derived Medical Product Market Drivers
11.2 Plasma-derived Medical Product Market Restraints
11.3 Plasma-derived Medical Product Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasma-derived Medical Product Industry Chain
12.2 Plasma-derived Medical Product Upstream Analysis
12.3 Plasma-derived Medical Product Midstream Analysis
12.4 Plasma-derived Medical Product Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Plasma-derived Medical Product Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Plasma-derived Medical Product Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Plasma-derived Medical Product Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Plasma-derived Medical Product Product and Solutions
Table 8. Takeda Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Takeda Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Plasma-derived Medical Product Product and Solutions
Table 13. CSL Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. CSL Recent Developments and Future Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Plasma-derived Medical Product Product and Solutions
Table 18. Grifols Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Grifols Recent Developments and Future Plans
Table 20. Octapharma Company Information, Head Office, and Major Competitors
Table 21. Octapharma Major Business
Table 22. Octapharma Plasma-derived Medical Product Product and Solutions
Table 23. Octapharma Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Octapharma Recent Developments and Future Plans
Table 25. Kedrion Company Information, Head Office, and Major Competitors
Table 26. Kedrion Major Business
Table 27. Kedrion Plasma-derived Medical Product Product and Solutions
Table 28. Kedrion Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Kedrion Recent Developments and Future Plans
Table 30. LFB Group Company Information, Head Office, and Major Competitors
Table 31. LFB Group Major Business
Table 32. LFB Group Plasma-derived Medical Product Product and Solutions
Table 33. LFB Group Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. LFB Group Recent Developments and Future Plans
Table 35. Biotest Company Information, Head Office, and Major Competitors
Table 36. Biotest Major Business
Table 37. Biotest Plasma-derived Medical Product Product and Solutions
Table 38. Biotest Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biotest Recent Developments and Future Plans
Table 40. BPL Company Information, Head Office, and Major Competitors
Table 41. BPL Major Business
Table 42. BPL Plasma-derived Medical Product Product and Solutions
Table 43. BPL Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BPL Recent Developments and Future Plans
Table 45. RAAS Company Information, Head Office, and Major Competitors
Table 46. RAAS Major Business
Table 47. RAAS Plasma-derived Medical Product Product and Solutions
Table 48. RAAS Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. RAAS Recent Developments and Future Plans
Table 50. CBPO Company Information, Head Office, and Major Competitors
Table 51. CBPO Major Business
Table 52. CBPO Plasma-derived Medical Product Product and Solutions
Table 53. CBPO Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. CBPO Recent Developments and Future Plans
Table 55. Hualan Bio Company Information, Head Office, and Major Competitors
Table 56. Hualan Bio Major Business
Table 57. Hualan Bio Plasma-derived Medical Product Product and Solutions
Table 58. Hualan Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Hualan Bio Recent Developments and Future Plans
Table 60. Tiantan Bio Company Information, Head Office, and Major Competitors
Table 61. Tiantan Bio Major Business
Table 62. Tiantan Bio Plasma-derived Medical Product Product and Solutions
Table 63. Tiantan Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Tiantan Bio Recent Developments and Future Plans
Table 65. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 66. Shuanglin Bio Major Business
Table 67. Shuanglin Bio Plasma-derived Medical Product Product and Solutions
Table 68. Shuanglin Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Shuanglin Bio Recent Developments and Future Plans
Table 70. Boya Bio Company Information, Head Office, and Major Competitors
Table 71. Boya Bio Major Business
Table 72. Boya Bio Plasma-derived Medical Product Product and Solutions
Table 73. Boya Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Boya Bio Recent Developments and Future Plans
Table 75. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 76. Yuanda Shuyang Major Business
Table 77. Yuanda Shuyang Plasma-derived Medical Product Product and Solutions
Table 78. Yuanda Shuyang Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Yuanda Shuyang Recent Developments and Future Plans
Table 80. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 81. Weiguang Bio Major Business
Table 82. Weiguang Bio Plasma-derived Medical Product Product and Solutions
Table 83. Weiguang Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Weiguang Bio Recent Developments and Future Plans
Table 85. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 86. Nanyue Bio Major Business
Table 87. Nanyue Bio Plasma-derived Medical Product Product and Solutions
Table 88. Nanyue Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nanyue Bio Recent Developments and Future Plans
Table 90. KM Biologics Company Information, Head Office, and Major Competitors
Table 91. KM Biologics Major Business
Table 92. KM Biologics Plasma-derived Medical Product Product and Solutions
Table 93. KM Biologics Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. KM Biologics Recent Developments and Future Plans
Table 95. Global Plasma-derived Medical Product Revenue (USD Million) by Players (2018-2023)
Table 96. Global Plasma-derived Medical Product Revenue Share by Players (2018-2023)
Table 97. Breakdown of Plasma-derived Medical Product by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Plasma-derived Medical Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Plasma-derived Medical Product Players
Table 100. Plasma-derived Medical Product Market: Company Product Type Footprint
Table 101. Plasma-derived Medical Product Market: Company Product Application Footprint
Table 102. Plasma-derived Medical Product New Market Entrants and Barriers to Market Entry
Table 103. Plasma-derived Medical Product Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Plasma-derived Medical Product Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Plasma-derived Medical Product Consumption Value Share by Type (2018-2023)
Table 106. Global Plasma-derived Medical Product Consumption Value Forecast by Type (2024-2029)
Table 107. Global Plasma-derived Medical Product Consumption Value by Application (2018-2023)
Table 108. Global Plasma-derived Medical Product Consumption Value Forecast by Application (2024-2029)
Table 109. North America Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Plasma-derived Medical Product Raw Material
Table 140. Key Suppliers of Plasma-derived Medical Product Raw Materials
Table 1. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Plasma-derived Medical Product Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Plasma-derived Medical Product Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Plasma-derived Medical Product Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Plasma-derived Medical Product Product and Solutions
Table 8. Takeda Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Takeda Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Plasma-derived Medical Product Product and Solutions
Table 13. CSL Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. CSL Recent Developments and Future Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Plasma-derived Medical Product Product and Solutions
Table 18. Grifols Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Grifols Recent Developments and Future Plans
Table 20. Octapharma Company Information, Head Office, and Major Competitors
Table 21. Octapharma Major Business
Table 22. Octapharma Plasma-derived Medical Product Product and Solutions
Table 23. Octapharma Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Octapharma Recent Developments and Future Plans
Table 25. Kedrion Company Information, Head Office, and Major Competitors
Table 26. Kedrion Major Business
Table 27. Kedrion Plasma-derived Medical Product Product and Solutions
Table 28. Kedrion Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Kedrion Recent Developments and Future Plans
Table 30. LFB Group Company Information, Head Office, and Major Competitors
Table 31. LFB Group Major Business
Table 32. LFB Group Plasma-derived Medical Product Product and Solutions
Table 33. LFB Group Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. LFB Group Recent Developments and Future Plans
Table 35. Biotest Company Information, Head Office, and Major Competitors
Table 36. Biotest Major Business
Table 37. Biotest Plasma-derived Medical Product Product and Solutions
Table 38. Biotest Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biotest Recent Developments and Future Plans
Table 40. BPL Company Information, Head Office, and Major Competitors
Table 41. BPL Major Business
Table 42. BPL Plasma-derived Medical Product Product and Solutions
Table 43. BPL Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BPL Recent Developments and Future Plans
Table 45. RAAS Company Information, Head Office, and Major Competitors
Table 46. RAAS Major Business
Table 47. RAAS Plasma-derived Medical Product Product and Solutions
Table 48. RAAS Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. RAAS Recent Developments and Future Plans
Table 50. CBPO Company Information, Head Office, and Major Competitors
Table 51. CBPO Major Business
Table 52. CBPO Plasma-derived Medical Product Product and Solutions
Table 53. CBPO Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. CBPO Recent Developments and Future Plans
Table 55. Hualan Bio Company Information, Head Office, and Major Competitors
Table 56. Hualan Bio Major Business
Table 57. Hualan Bio Plasma-derived Medical Product Product and Solutions
Table 58. Hualan Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Hualan Bio Recent Developments and Future Plans
Table 60. Tiantan Bio Company Information, Head Office, and Major Competitors
Table 61. Tiantan Bio Major Business
Table 62. Tiantan Bio Plasma-derived Medical Product Product and Solutions
Table 63. Tiantan Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Tiantan Bio Recent Developments and Future Plans
Table 65. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 66. Shuanglin Bio Major Business
Table 67. Shuanglin Bio Plasma-derived Medical Product Product and Solutions
Table 68. Shuanglin Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Shuanglin Bio Recent Developments and Future Plans
Table 70. Boya Bio Company Information, Head Office, and Major Competitors
Table 71. Boya Bio Major Business
Table 72. Boya Bio Plasma-derived Medical Product Product and Solutions
Table 73. Boya Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Boya Bio Recent Developments and Future Plans
Table 75. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 76. Yuanda Shuyang Major Business
Table 77. Yuanda Shuyang Plasma-derived Medical Product Product and Solutions
Table 78. Yuanda Shuyang Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Yuanda Shuyang Recent Developments and Future Plans
Table 80. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 81. Weiguang Bio Major Business
Table 82. Weiguang Bio Plasma-derived Medical Product Product and Solutions
Table 83. Weiguang Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Weiguang Bio Recent Developments and Future Plans
Table 85. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 86. Nanyue Bio Major Business
Table 87. Nanyue Bio Plasma-derived Medical Product Product and Solutions
Table 88. Nanyue Bio Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nanyue Bio Recent Developments and Future Plans
Table 90. KM Biologics Company Information, Head Office, and Major Competitors
Table 91. KM Biologics Major Business
Table 92. KM Biologics Plasma-derived Medical Product Product and Solutions
Table 93. KM Biologics Plasma-derived Medical Product Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. KM Biologics Recent Developments and Future Plans
Table 95. Global Plasma-derived Medical Product Revenue (USD Million) by Players (2018-2023)
Table 96. Global Plasma-derived Medical Product Revenue Share by Players (2018-2023)
Table 97. Breakdown of Plasma-derived Medical Product by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Plasma-derived Medical Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Plasma-derived Medical Product Players
Table 100. Plasma-derived Medical Product Market: Company Product Type Footprint
Table 101. Plasma-derived Medical Product Market: Company Product Application Footprint
Table 102. Plasma-derived Medical Product New Market Entrants and Barriers to Market Entry
Table 103. Plasma-derived Medical Product Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Plasma-derived Medical Product Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Plasma-derived Medical Product Consumption Value Share by Type (2018-2023)
Table 106. Global Plasma-derived Medical Product Consumption Value Forecast by Type (2024-2029)
Table 107. Global Plasma-derived Medical Product Consumption Value by Application (2018-2023)
Table 108. Global Plasma-derived Medical Product Consumption Value Forecast by Application (2024-2029)
Table 109. North America Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Plasma-derived Medical Product Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Plasma-derived Medical Product Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Plasma-derived Medical Product Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Plasma-derived Medical Product Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Plasma-derived Medical Product Raw Material
Table 140. Key Suppliers of Plasma-derived Medical Product Raw Materials
LIST OF FIGURES
Figure 1. Plasma-derived Medical Product Picture
Figure 2. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Plasma-derived Medical Product Consumption Value Market Share by Type in 2022
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Albumin
Figure 7. Others
Figure 8. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Plasma-derived Medical Product Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Plasma-derived Medical Product Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Plasma-derived Medical Product Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Plasma-derived Medical Product Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Plasma-derived Medical Product Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Plasma-derived Medical Product Consumption Value Market Share by Region in 2022
Figure 18. North America Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Plasma-derived Medical Product Revenue Share by Players in 2022
Figure 24. Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Plasma-derived Medical Product Market Share in 2022
Figure 26. Global Top 6 Players Plasma-derived Medical Product Market Share in 2022
Figure 27. Global Plasma-derived Medical Product Consumption Value Share by Type (2018-2023)
Figure 28. Global Plasma-derived Medical Product Market Share Forecast by Type (2024-2029)
Figure 29. Global Plasma-derived Medical Product Consumption Value Share by Application (2018-2023)
Figure 30. Global Plasma-derived Medical Product Market Share Forecast by Application (2024-2029)
Figure 31. North America Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 41. France Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Region (2018-2029)
Figure 48. China Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 51. India Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 65. Plasma-derived Medical Product Market Drivers
Figure 66. Plasma-derived Medical Product Market Restraints
Figure 67. Plasma-derived Medical Product Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Plasma-derived Medical Product in 2022
Figure 70. Manufacturing Process Analysis of Plasma-derived Medical Product
Figure 71. Plasma-derived Medical Product Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Plasma-derived Medical Product Picture
Figure 2. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Plasma-derived Medical Product Consumption Value Market Share by Type in 2022
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Albumin
Figure 7. Others
Figure 8. Global Plasma-derived Medical Product Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Plasma-derived Medical Product Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Plasma-derived Medical Product Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Plasma-derived Medical Product Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Plasma-derived Medical Product Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Plasma-derived Medical Product Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Plasma-derived Medical Product Consumption Value Market Share by Region in 2022
Figure 18. North America Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Plasma-derived Medical Product Revenue Share by Players in 2022
Figure 24. Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Plasma-derived Medical Product Market Share in 2022
Figure 26. Global Top 6 Players Plasma-derived Medical Product Market Share in 2022
Figure 27. Global Plasma-derived Medical Product Consumption Value Share by Type (2018-2023)
Figure 28. Global Plasma-derived Medical Product Market Share Forecast by Type (2024-2029)
Figure 29. Global Plasma-derived Medical Product Consumption Value Share by Application (2018-2023)
Figure 30. Global Plasma-derived Medical Product Market Share Forecast by Application (2024-2029)
Figure 31. North America Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 41. France Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Plasma-derived Medical Product Consumption Value Market Share by Region (2018-2029)
Figure 48. China Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 51. India Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Plasma-derived Medical Product Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Plasma-derived Medical Product Consumption Value (2018-2029) & (USD Million)
Figure 65. Plasma-derived Medical Product Market Drivers
Figure 66. Plasma-derived Medical Product Market Restraints
Figure 67. Plasma-derived Medical Product Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Plasma-derived Medical Product in 2022
Figure 70. Manufacturing Process Analysis of Plasma-derived Medical Product
Figure 71. Plasma-derived Medical Product Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
